Kiniksa Pharmaceuticals International (KNSA) Other Gross PP&E Adjustments (2017 - 2026)
Kiniksa Pharmaceuticals International filings provide 7 years of Other Gross PP&E Adjustments readings, the most recent being -$5.8 million for Q1 2026.
- On a quarterly basis, Other Gross PP&E Adjustments rose 5.64% to -$5.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$5.8 million, a 5.64% increase, with the full-year FY2025 number at -$6.0 million, up 66.43% from a year prior.
- Other Gross PP&E Adjustments hit -$5.8 million in Q1 2026 for Kiniksa Pharmaceuticals International, up from -$6.0 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $1.8 million in Q2 2022 to a low of -$19.1 million in Q4 2023.
- Median Other Gross PP&E Adjustments over the past 5 years was -$7.0 million (2025), compared with a mean of -$8.0 million.
- Biggest five-year swings in Other Gross PP&E Adjustments: soared 90.97% in 2023 and later crashed 1309.33% in 2024.
- Kiniksa Pharmaceuticals International's Other Gross PP&E Adjustments stood at -$8.7 million in 2022, then crashed by 120.1% to -$19.1 million in 2023, then increased by 6.49% to -$17.8 million in 2024, then skyrocketed by 66.43% to -$6.0 million in 2025, then rose by 2.91% to -$5.8 million in 2026.
- The last three reported values for Other Gross PP&E Adjustments were -$5.8 million (Q1 2026), -$6.0 million (Q4 2025), and -$4.9 million (Q3 2025) per Business Quant data.